Cargando…
Endothelial arginase II and atherosclerosis
Atherosclerotic vascular disease is the leading cause of morbidity and mortality in developed countries. While it is a complex condition resulting from numerous genetic and environmental factors, it is well recognized that oxidized low-density lipoprotein produces pro-atherogenic effects in endothel...
Autores principales: | Ryoo, Sungwoo, Berkowitz, Dan E., Lim, Hyun Kyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Anesthesiologists
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155133/ https://www.ncbi.nlm.nih.gov/pubmed/21860744 http://dx.doi.org/10.4097/kjae.2011.61.1.3 |
Ejemplares similares
-
Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice
por: Shin, Woosung, et al.
Publicado: (2012) -
Korean Red Ginseng Water Extract Restores Impaired Endothelial Function by Inhibiting Arginase Activity in Aged Mice
por: Choi, Kwanhoon, et al.
Publicado: (2014) -
Intravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged mice
por: Nguyen, Minh Cong, et al.
Publicado: (2017) -
Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation
por: Nguyen, Minh Cong, et al.
Publicado: (2016) -
Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca(2+)-dependent eNOS activation
por: Koo, Bon-Hyeock, et al.
Publicado: (2021)